Hops

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: sleep stress anxiety

Research Overview

Overall, hop (Humulus lupulus) research is dominated by chemical characterization and preclinical bioactivity studies of its major secondary metabolite classes: polyphenols (notably prenylated flavonoids such as xanthohumol), essential oils (e.g., β-myrcene and other terpenes), and resins/bitter acids (α- and β-acids). Reviews emphasize extensive work on extraction, fractionation, and analytical methods, alongside in vitro and animal-model testing for antioxidative, antimicrobial, antigenotoxic, anti-inflammatory, sedative/neuropharmacological, and anticancer-related effects. A parallel applied research stream focuses on food and beverage innovation—especially beer as a delivery matrix—including emerging interest in functional products such as non-alcoholic beers enriched in specific hop volatiles (e.g., β-myrcene) and “probiotic beers,” where the main challenges are strain selection, viability, and stability in the beer environment.

The strongest evidence base supports that hops contain chemically diverse compounds with measurable biological activities in experimental systems, with particularly consistent preclinical support for antioxidant/anti-inflammatory effects and anticancer activity of specific constituents such as xanthohumol. There is also substantial mechanistic and pharmacological rationale for estrogenic activity from hop prenylflavonoids (often highlighted in the context of women’s health and menopausal symptoms), and for antimicrobial contributions relevant to beer stability. However, across these domains the studies collectively indicate that much of the evidence remains preclinical (cell/animal studies) or mechanistic, rather than derived from rigorous human trials demonstrating clinically meaningful outcomes.

Key research gaps include well-designed human studies to establish efficacy, dose–response relationships, and safety for isolated hop constituents (e.g., β-myrcene) and standardized hop extracts, including evaluation of long-term exposure and potential drug–botanical interactions—an issue emphasized for botanicals used in women’s health. Additional needs include improving bioavailability (e.g., via encapsulation), testing synergistic effects among hop compounds, and developing standardized, reproducible formulations suitable for clinical evaluation. On the applied side, probiotic beer research requires more work on microbial survival, sensory impacts, and regulatory/safety considerations, while sustainability-oriented studies (e.g., valorization of brewery hop biomass within biorefinery concepts) are identified as promising but still developing areas.

1. What conditions has Hops been studied for?

  • Cancer (chemoprevention/anticancer activity): Multiple studies discuss anticancer properties of hop prenylflavonoids, especially xanthohumol (XH/Xn), described as selectively affecting cancer cells in numerous studies (largely preclinical).

  • Menopausal symptoms / women’s health (as an alternative to hormone therapy): Hops (Humulus lupulus) is listed among botanicals with estrogenic activity used for menopausal symptom relief; hop prenylflavonoids (notably 8-prenylnaringenin) are highlighted as potent phytoestrogens.

  • Sedation / neuropharmacologic effects (e.g., calming/sleep-related uses): Reviews describe hop oils and resins as having sedative and other neuropharmacological properties.

  • Inflammation, oxidative stress, pain-related outcomes (general): Reviews attribute antioxidant and anti-inflammatory effects to hop compounds; the hop constituent β-myrcene (present in hops) is discussed for anxiolytic, anti-inflammatory, analgesic, antioxidant properties (mostly animal data).

  • Metabolic syndrome / lifestyle-related metabolic disorders: One review states alpha bitter acids have been shown to block development of “complex lifestyle diseases” grouped as metabolic syndrome (evidence type not specified in the study; commonly preclinical/early translational).

  • Antimicrobial/antifungal applications: Reviews note hop compounds contribute to antimicrobial protection (including antibacterial and antifungal effects), relevant to food/beer stability and potentially other applications.

  • Bone health/osteoporosis (indirectly, via estrogenic botanicals): The women’s health review notes some estrogenic botanicals (including hops) have been shown to have protective effects against osteoporosis (not specific to hops in the study).

2. Does it work in treating those conditions? Summarize the evidence.

  • Menopausal symptoms: The studies indicate hops is used for menopausal symptom relief due to estrogenic activity, but they also emphasize that botanicals are often not rigorously tested for efficacy and safety, and that rigorous clinical trials are lacking for several women’s health botanicals. Based on these studies alone, evidence for clinical effectiveness is suggestive but not confirmed.

  • Cancer/chemoprevention: Xanthohumol is described as having anticancer activity in “numerous studies,” and hop reviews highlight anticarcinogenic features. However, the studies do not cite human clinical outcomes; the framing strongly suggests the evidence base is primarily preclinical (cell/animal). Therefore, effectiveness for treating or preventing cancer in humans is not established from these studies.

  • Sedation/anxiety-related effects: Hop oils/resins are described as sedative, and β-myrcene is described as anxiolytic in animal studies. The β-myrcene abstract explicitly states that while benefits are promising in animals, human studies are lacking. So, clinical effectiveness in humans is uncertain based on these studies.

  • Metabolic syndrome: One review states alpha bitter acids have been shown to block development of metabolic syndrome-related diseases, but without details on study design or human endpoints in the study. From these studies, evidence is insufficient to conclude clinical efficacy.

  • Antimicrobial effects: Hops’ antimicrobial role in beer is well-recognized and reiterated (taste, stability, antimicrobial protection). This supports functional antimicrobial activity in the beer/food context, but it does not directly establish effectiveness as a clinical antimicrobial treatment.

Overall, across the studies, hops and its constituents show broad biological activity, but human clinical evidence is limited or not presented, and several reviews explicitly highlight the need for more rigorous trials.

3. What health benefits does it have?

  • Antioxidant effects: Hop compounds are repeatedly described as having antioxidative potential; β-myrcene is also described as antioxidant.

  • Anti-inflammatory effects: Reviews cite anti-inflammatory potential; β-myrcene is also described as anti-inflammatory.

  • Potential anticancer/chemopreventive activity: Prenylated flavonoids from hops (notably xanthohumol) are highlighted for anticancer activity in numerous studies (largely preclinical).

  • Estrogenic/phytoestrogen activity: Prenylflavonoids (notably 8-prenylnaringenin) are described as among the most active phytoestrogens known, supporting the rationale for menopausal symptom use and possible bone-related benefits (though clinical confirmation is not provided in these studies).

  • Sedative/neuropharmacologic properties: Hop oils and resins are described as sedative and neuropharmacologically active; β-myrcene is discussed for anxiolytic and analgesic properties (animal data emphasized).

  • Antibacterial/antifungal effects: Hop oils/resins exhibit antibacterial and antifungal effects; hops contribute antimicrobial protection in beer.

  • Potential metabolic benefits: Alpha bitter acids are described as blocking development of diseases grouped under “metabolic syndrome” (details not provided in the study).

4. Does it have any downsides or side effects?

  • Limited rigorous safety testing and interaction risk: The women’s health review cautions that botanicals are perceived as safe but often have not been rigorously tested for toxic effects and/or drug–botanical interactions. A separate survey abstract highlights that concurrent use of herbal medicinal products/dietary supplements with prescription drugs is common in older adults and underscores the need to identify potential interactions (not hops-specific, but relevant to hops use in this population).

  • Hormonal/estrogenic considerations: Because hops has estrogenic activity (potent phytoestrogens such as 8-prenylnaringenin), a plausible downside is hormone-related effects or contraindications in hormone-sensitive conditions. The studies do not provide specific adverse event rates, but they do emphasize the need for safety awareness.

  • Metabolism and exposure considerations: Pharmacokinetic information indicates hop prenylflavonoids are rapidly conjugated with glucuronic acid and xanthohumol undergoes metabolism to other flavonoids (IX, 8-PN, 6-PN). This suggests variable internal exposure and potential variability in effects across individuals, but the studies do not specify adverse outcomes from these processes.

  • β-myrcene safety: The β-myrcene review notes it discusses “recent data regarding the safety of β-myrcene,” but the study’s main takeaway is that human studies are lacking, so definitive human safety conclusions are limited from the provided text.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report specific pharmacogenomic findings (e.g., gene variants predicting response, toxicity, or metabolism) for hops or its key constituents.

  • What can be inferred (limited): The pharmacokinetic abstract notes rapid glucuronidation of prenylflavonoids and metabolic conversion of xanthohumol to other compounds (IX, 8-PN, 6-PN). In principle, genetic variation in drug-metabolizing enzymes involved in conjugation (e.g., UGT enzymes) could alter exposure, but this is not directly studied or demonstrated in the studies reviewed here.

  • Practical implication: Because interaction and safety data are limited and polypharmacy is common in older adults, individual variability (including genetics) may matter, but no evidence-based genotype-guided recommendations can be made from these studies.

References

  1. Myrcene-What Are the Potential Health Benefits of This Flavouring and Aroma Agent?
    Shelini Surendran, Fatimah Qassadi, Geyan Surendran, Dash Lilley, Michael Heinrich (2021) - Frontiers in nutrition
  2. Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (
    Chuan-Hao Jiang, Tao-Li Sun, Da-Xiong Xiang, Shan-Shan Wei, Wen-Qun Li (2018) - Frontiers in pharmacology
  3. Effect of aquatic versus conventional physical therapy program on ankle sprain grade III in elite athletes: randomized controlled trial.
    Maryam M Sadaak, Salwa Fadl AbdElMageed, Mona Mohamed Ibrahim (2024) - Journal of orthopaedic surgery and research
  4. Hop Compounds: Extraction Techniques, Chemical Analyses, Antioxidative, Antimicrobial, and Anticarcinogenic Effects.
    Maša Knez Hrnčič, Eva Španinger, Iztok Jože Košir, Željko Knez, Urban Bren (2019) - Nutrients
  5. Botanicals and Their Bioactive Phytochemicals for Women's Health.
    Birgit M Dietz, Atieh Hajirahimkhan, Tareisha L Dunlap, Judy L Bolton (2016) - Pharmacological reviews
  6. Biologically Active Compounds from Hops and Prospects for Their Use.
    Marcel Karabín, Tereza Hudcová, Lukáš Jelínek, Pavel Dostálek (2016) - Comprehensive reviews in food science and food safety
  7. Exploring the potential of probiotic-enriched beer: Microorganisms, fermentation strategies, sensory attributes, and health implications.
    Carlo R Hinojosa-Avila, Ricardo García-Gamboa, Jorge J T Chedraui-Urrea, Tomás García-Cayuela (2024) - Food research international (Ottawa, Ont.)
  8. Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.
    Nuria Salazar, Miguel Gueimonde, Clara G de Los Reyes-Gavilán, Patricia Ruas-Madiedo (2016) - Critical reviews in food science and nutrition
  9. Application of amino acids nitrogen stable isotopic analysis in bioaccumulation studies of pollutants: A review.
    Yiye Jiang, Yanhong Zeng, Ruifeng Lu, Yanting Zhang, Ling Long, Xiaobo Zheng, Xiaojun Luo, Bixian Mai (2023) - The Science of the total environment
  10. Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops.
    Kateřina Štulíková, Marcel Karabín, Jakub Nešpor, Pavel Dostálek (2018) - Molecules (Basel, Switzerland)
  11. Antioxidants in Hops: Bioavailability, Health Effects and Perspectives for New Products.
    Corina-Aurelia Zugravu, Roxana-Elena Bohiltea, Teodor Salmen, Elena Pogurschi, Marina Ruxandra Otelea (2022) - Antioxidants (Basel, Switzerland)
  12. Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.
    Taofikat B Agbabiaka, Neil H Spencer, Sabina Khanom, Claire Goodman (2018) - The British journal of general practice : the journal of the Royal College of General Practitioners
  13. The Multiple Biological Targets of Hops and Bioactive Compounds.
    Judy L Bolton, Tareisha L Dunlap, Atieh Hajirahimkhan, Obinna Mbachu, Shao-Nong Chen, Luke Chadwick, Dejan Nikolic, Richard B van Breemen, Guido F Pauli, Birgit M Dietz (2019) - Chemical research in toxicology
  14. CORVET, CHEVI and HOPS - multisubunit tethers of the endo-lysosomal system in health and disease.
    Jan van der Beek, Caspar Jonker, Reini van der Welle, Nalan Liv, Judith Klumperman (2019) - Journal of cell science
  15. Interactions between humulinone derived from aged hops and protein Z enhance the foamability and foam stability.
    Chen Xu, Xuanqi Zhang, Mingyang Sun, Hanhan Liu, Chenyan Lv (2024) - Food chemistry
  16. Hop Latent Viroid: A Hidden Threat to the Cannabis Industry.
    Charith Raj Adkar-Purushothama, Teruo Sano, Jean-Pierre Perreault (2023) - Viruses
  17. Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment.
    Shadi Vesaghhamedani, Farnoosh Ebrahimzadeh, Elnaz Najafi, Omid Gohari Shabgah, Elham Askari, Arezoo Gowhari Shabgah, Hamed Mohammadi, Farhad Jadidi-Niaragh, Jamshid Gholizadeh Navashenaq (2022) - Progress in biophysics and molecular biology
  18. Herbal Products Used in Menopause and for Gynecological Disorders.
    Maša Kenda, Nina Kočevar Glavač, Milan Nagy, Marija Sollner Dolenc, On Behalf Of The Oemonom (2021) - Molecules (Basel, Switzerland)
  19. Physiological Mechanisms by Which the Functional Ingredients in Beer Impact Human Health.
    Yawen Zeng, Hafiz Ghulam Muhu-Din Ahmed, Xia Li, Li'e Yang, Xiaoying Pu, Xiaomeng Yang, Tao Yang, Jiazhen Yang (2024) - Molecules (Basel, Switzerland)
  20. Repurposing of halogenated organic pollutants via alkyl bromide-catalysed transfer chlorination.
    Heng Liu, Ding-Wei Ji, Yong-Kang Mei, Yan Liu, Chang-Hui Liu, Xiao-Yu Wang, Qing-An Chen (2024) - Nature chemistry


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!